STE STERIS plc (Ireland) Ordinary Shares

NYSE · US · Healthcare · Medical Devices · steris.com

208.68USD+0.07%Mkt Cap: 20.33B $P/E: 25.46Today

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. Th…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

$11.06BUSDP/E 18.0

GMED

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

GKOS

Glaukos Corporation Common Stock

$9.66BUSD

BRKR

Bruker Corporation - Common Stock

$9.64BUSD

Key Statistics

Company

Market Cap20.33B USD

Enterprise Value21.91B USD

Revenue (TTM)6.04B USD

Gross Profit2.63B USD

Net Income (TTM)782.30M USD

Revenue/Share61.61 USD

Last Price208.68 USD

Fiscal Year EndMar 2026

MR QuarterJun 2026

Employees17.9K

CountryUS

SectorHealthcare

IndustryMedical Devices

ISIN—

Valuation

P/E (Trailing)25.46

P/E (Forward)17.03

PEG1.74

EV/EBITDA13.36

EV/Revenue3.63

P/S3.37

P/B2.82

EPS (TTM)8.18

EPS (Forward)12.25

52W Range

195.1418% of range269.44

52W High269.44 USD

52W Low195.14 USD

Profitability

Gross Margin44.25%

Oper. Margin19.15%

EBITDA Margin27.17%

Profit Margin13.18%

ROE10.89%

ROA7.29%

Growth

Revenue Growth7.30%

Earnings Growth14.00%

Cash Flow & Leverage

Operating CF1.34B USD

CapEx (TTM)369.00M USD

FCF Margin13.23%

FCF Yield3.93%

Net Debt1.56B USD

Net Debt/EBITDA0.95

Balance Sheet

Debt/Equity0.29

Current Ratio1.91

Quick Ratio1.17

Book Value/Sh73.92 USD

Cash/Share4.95 USD

Dividends

Fwd Div Rate2.58 USD

Trail. Div Rate2.52 USD

Div. Yield1.24%

5Y Avg Yield0.91%

Payout Ratio30.81%

Ex-Div DateSep 4, 2026

Pay DateSep 25, 2026

Splits

Last Split2:1

Split DateAug 25, 1998

Analyst Consensus

Rating1.8 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)263.13 USD

Upside (mean)+26.1%

Target Range232.00 USD – 280.00 USD

232.00+26.1% to mean280.00

# Analysts8

Ownership

Shares Out.97.50M

Float97.08M

Insiders0.31%

Institutions100.74%

Short Interest

Short Ratio4.6d

Short % Float2.87%

Short % Out.2.86%

Shares Short2.79M

Short (prev mo.)2.32M

Technical

SMA 50223.98 (-6.8%)

SMA 200228.18 (-8.5%)

Beta0.91

S&P 52W Chg14.58%

Avg Vol (30d)596.67K

Avg Vol (10d)588.38K

Technical Indicators

RSI (14)35.7

MACD-4.1935

MACD Signal-4.6880

MACD Hist.+0.4945

BB Upper219.69 USD

BB Middle211.06 USD

BB Lower202.44 USD

BB Width8.17%

ATR (14)4.102 USD

Vol Ratio (20d)1.07x